State Street Corp Insmed Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Insmed Inc stock. As of the latest transaction made, State Street Corp holds 6,178,230 shares of INSM stock, worth $481 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,178,230

Previous 4,662,439 32.51%

Holding current value

$481 Million

Previous $312 Million 44.38%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $94 Million - $120 Million	1,515,791 Added 32.51%	6,178,230 $451 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $27.3 Million - $86.6 Million	-1,242,688 Reduced 21.04%	4,662,439 $312 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $638,010 - $742,691	-24,806 Reduced 0.42%	5,905,127 $160 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $20.5 Million - $27.8 Million	875,550 Added 17.32%	5,929,933 $184 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $19.2 Million - $26 Million	-966,196 Reduced 16.05%	5,054,383 $128 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $5.01 Million - $6.43 Million	-304,626 Reduced 4.82%	6,020,579 $127 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $9.13 Million - $12.2 Million	-561,482 Reduced 8.15%	6,325,205 $108 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $24.4 Million - $33.2 Million	1,435,270 Added 26.33%	6,886,687 $138 Million
Q3 2022 Nov 15, 2022	SELL	$20.88 - $28.21 $7.68 Million - $10.4 Million	-367,655 Reduced 6.32%	5,451,417 $117 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $11.9 Million - $17.9 Million	697,428 Added 13.62%	5,819,072 $115 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $15.7 Million - $21.6 Million	767,876 Added 17.64%	5,121,644 $120 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $4.92 Million - $6.36 Million	190,155 Added 4.57%	4,353,768 $119 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $13.2 Million - $17.4 Million	589,305 Added 16.49%	4,163,613 $115 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $8.32 Million - $12.4 Million	344,203 Added 10.66%	3,574,308 $102 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $11.7 Million - $16.1 Million	-363,565 Reduced 10.12%	3,230,105 $110 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $4.19 Million - $5.39 Million	-133,069 Reduced 3.57%	3,593,670 $120 Million
Q3 2020 Nov 10, 2020	SELL	$26.0 - $34.5 $7.65 Million - $10.1 Million	-294,108 Reduced 7.31%	3,726,739 $120 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $7.98 Million - $16.6 Million	565,357 Added 16.36%	4,020,847 $111 Million
Q1 2020 May 11, 2020	BUY	$13.63 - $33.98 $47.1 Million - $117 Million	3,455,490 New	3,455,490 $55.4 Million

Others Institutions Holding INSM

# of Institutions

475

Shares Held

179M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.5B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Insmed Inc Transaction History